Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of ZX2010 in Chinese adults with type 2 diabetes mellitus
CTR20252333Phase 2Active
- Sponsor
- Jiangsu Zhongxin Pharmaceutical
- Start
- Jul 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ZX2010 in type 2 diabetes mellitus (T2DM), sponsored by Jiangsu Zhongxin Pharmaceutical. Started Jul 2025; status: active.
02
Drugs
ZX2010
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20252333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252333.